CHAR

Business Context and Reporting Period

Company: Charlton Aria Acquisition Corp (Nasdaq: CHARU, CHAR, CHARR)
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended December 31, 2024 (Inception: March 22, 2024)
Business Model: Cayman Islands exempted company (SPAC) formed to effect an initial business combination. The Company has no operations and no revenue to date. It is classified as a shell company and an emerging growth company.

Key Financial Metrics

Note: The Company generated no operating revenue. Net income was driven by dividend income on trust investments ($657,624) and a change in fair value of the over-allotment option liability ($197,895), offset by formation/operating costs ($341,598) and stock-based compensation ($249,695).

Material Changes and Capital Events

• Initial Public Offering (IPO): Consummated on October 25, 2024. Sold 7,500,000 Units at $10.00 per unit, generating $75,000,000 in gross proceeds.
• Over-Allotment Exercise: On November 19, 2024, underwriters exercised the option in part to purchase 1,000,000 additional Units, generating $10,000,000 in gross proceeds.
• Private Placements: Simultaneously with the IPO and over-allotment, the Sponsor purchased 255,000 Private Placement Units for $2,550,000.
• Trust Account Funding: A total of $85,212,500 was deposited into the trust account ($10.025 per public unit). As of December 31, 2024, the trust balance grew to $85,870,124 due to investment income.
• Founder Shares: 31,250 Class B shares were forfeited to maintain the Sponsor's 20% ownership stake post-IPO.

Outlook, Risks, and Management Commentary

• Combination Deadline: The Company must complete an initial business combination by April 25, 2026 (18 months from IPO). This can be extended twice by three months each (up to October 25, 2026) if the Sponsor deposits $850,000 ($0.10 per unit) per extension into the trust.
• Going Concern: Management has raised substantial doubt about the Company's ability to continue as a going concern if a business combination is not completed by the deadline. The financial statements do not include adjustments that might result from this uncertainty.
• Internal Controls: Management identified a material weakness in internal controls over financial reporting due to inadequate segregation of duties and insufficient written policies. Remediation plans include enhancing board composition and hiring third-party professionals.
• Legal Proceedings: The Company disclosed pending derivative lawsuits (Jie Action and Samuels Action) involving former officers and directors of Nova Lifestyle, Inc., in which current directors are named. The cases were consolidated and the stay lifted in January 2025.
• Redemption Rights: Public shareholders may redeem shares for a pro-rata portion of the trust account (approx. $10.10 per share as of Dec 31, 2024) upon the completion of a business combination or liquidation.

Investor Verification Checklist

• Trust Account Balance: Verify the current balance of the trust account ($85.87M) and the per-share redemption value, noting that interest income is reinvested.
• Extension Terms: Confirm the Sponsor's ability and willingness to fund the $850,000 extension payments if the April 2026 deadline is missed.
• Internal Control Remediation: Monitor progress on fixing the material weakness in internal controls, specifically regarding segregation of duties.
• Legal Exposure: Track the status of the consolidated derivative lawsuits involving directors Umesh Patel and others, as this could impact management stability.
• Target Criteria: Review future disclosures to ensure any proposed target meets the 80% of net assets test required by Nasdaq rules.